Immunologic tolerability profile of celecoxib
- 1 December 1999
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (12) , 2065-2079
- https://doi.org/10.1016/s0149-2918(00)87238-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsArthritis & Rheumatism, 1998
- Glutathione in Hypersensitivity to Trimethoprim/Sulfamethoxazole in Patients with HIV InfectionAnnals of Pharmacotherapy, 1998
- Synthesis and Biological Evaluation of the 1,5-Diarylpyrazole Class of Cyclooxygenase-2 Inhibitors: Identification of 4-[5-(4-Methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC-58635, Celecoxib)Journal of Medicinal Chemistry, 1997
- Immunochemical analysis of sulfonamide drug allergy: Identification of sulfamethoxazole-substituted human serum proteinsJournal of Allergy and Clinical Immunology, 1994
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Toxicity of Nonsteroidal Anti-Inflammatory DrugsDrugs, 1993
- Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-l-tyrosineJournal of Allergy and Clinical Immunology, 1991
- Cross-reactions among furosemide, hydrochlorothiazide, and sulfonamidesJAMA, 1991
- Drugs as allergens: Detection and combining site specificities of IgE antibodies to sulfamethoxazoleMolecular Immunology, 1988
- Studies of human IgE to a sulfonamide determinantJournal of Allergy and Clinical Immunology, 1987